Back
ESC2025 Premium Access

Real-world use of oral semaglutide in adults with type 2 diabetes: the PIONEER REAL Switzerland multicentre, prospective, observational study

Session: Cardiometabolic and diabetes
Topic: Diabetes and the Heart
Speaker: Doctor F. Acquistapace (Lugano, CH)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Flavio Acquistapace

Medical in Practice Association, Lugano (Switzerland)
0 follower

3 more presentations in this session

Serum iron predicts long-term cardiovascular outcomes in diabetic patients with coronary artery disease, independent of iron status

Speaker: Doctor J. Cheng (Beijing, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Baseline characteristics and clinical outcomes of patients with type 2 diabetes and cardiovascular disease treated with GLP-1 receptor agonists and SGLT2 inhibitors

Speaker: Doctor R. Hilu (Kfar Saba, IL)

Access
Abstract
Slides
Video
Like
Thumbnail

Effect of oral semaglutide on remnant-like lipoprotein cholesterol in patients with ischemic heart disease receiving statin therapy

Speaker: Doctor S. Watanabe (Tokyo, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Cardiometabolic and diabetes

Speakers: Doctor F. Acquistapace, Doctor J. Cheng, Doctor R. Hilu, Doctor S. Watanabe
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources